Publication | Closed Access
Comparison of the clinical utility of tocilizumab and anti-TNF therapy in AA amyloidosis complicating rheumatic diseases
72
Citations
17
References
2013
Year
Based on these results, we conclude that TCZ was of greater clinical utility than anti-TNF therapy in our patients with AA amyloidosis complicating rheumatic diseases.
| Year | Citations | |
|---|---|---|
Page 1
Page 1